ZoomMed Inc.: Filing of the Annual Financial Statements

ZoomMed Inc.: Filing of the Annual Financial Statements

ID: 345015

(firmenpresse) - MONTREAL, QUEBEC -- (Marketwired) -- 10/17/14 -- ZoomMed Inc. (TSX VENTURE: ZMD) - ZoomMed announces that it has proceed today with the filing of its audited annual financial statements, the management discussion and analysis and the chief executive officer and chief financial officer certifications for the year ended May 31, 2014.

The Corporation has got from the proper securities regulatory authorities a management cease trade order under the Policy Statement 12-203 Respecting cease trade orders for continuous disclosure defaults (the "Policy Statement 12-203"). As of the date of this news release, the Corporation is not subjet to any insolvency proceedings and no other important information on the Corporation's business had not already been made public. Except as disclosed in the press release, there are no material change to the information contained in the last press release regarding the present matter and no subsequent default is anticipated.

About ZoomMed

ZoomMed builds and operates "ZoomMed's communication network", a clinical information exchange platform between physicians and the various other stakeholders of the healthcare sector, such as pharmacists, specialists, pharmaceutical corporations and private insurers. The cornerstone of this network is ZoomMed's "ZRx Prescriber", a technological innovative Web application that greatly simplifies the writing of a prescription for the physician. Since it is a stand-alone product, it can easily be integrated to any Electronic Medical Record application (EMR).

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Statements made in this news release that are not historical facts are "forward-looking statements" and readers are cautioned that any such statements are not guarantees of future performance, and that actual developments or results, may vary materially from those in these "forward-looking" statements.







Contacts:
ZoomMed Inc.
Mr. Yves Marmet
President and Chief Executive Officer
(450) 678-5457, Ext 228

Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  Medicure Reports Financial Results for the First Quarter Fiscal 2015 Rosetta Genomics and the Institute of Molecular Translational Medicine Partner on Development of Thyroid Cancer Diagnostic
Bereitgestellt von Benutzer: Marketwired
Datum: 17.10.2014 - 20:17 Uhr
Sprache: Deutsch
News-ID 345015
Anzahl Zeichen: 0

contact information:
Town:

MONTREAL, QUEBEC



Kategorie:

Medical Devices



Diese Pressemitteilung wurde bisher 215 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"ZoomMed Inc.: Filing of the Annual Financial Statements"
steht unter der journalistisch-redaktionellen Verantwortung von

ZoomMed Inc. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

Annual and Special Shareholders Meeting of ZoomMed Inc. ...

MONTREAL, QUEBEC -- (Marketwired) -- 11/29/16 -- ZoomMed Inc. (TSX VENTURE: ZMD), announces it has held its Annual and Special Meeting of Shareholders on November 29, 2016.The meeting was held for the purpose of:Shareholders voted overwhelmingly in ...

ZoomMed Announces the Grant of Options ...

MONTREAL, QUEBEC -- (Marketwired) -- 01/21/16 -- ZoomMed inc. (TSX VENTURE: ZMD) announces that during its Board of directors held on January 15, 2016, the Board agreed to grant options allows its holder to purchase one common share of ZoomMed at a ...

Alle Meldungen von ZoomMed Inc.



 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z